Project Details
Project Description
As requested by GSK, we have agreed to use our existing lupus cost data to prepare cost regression modelling report in line with GSK internal costing procedures.
| Status | Finished |
|---|---|
| Effective start/end date | 17/12/18 → 16/12/20 |
Funding
- GlaxoSmithKline (GSK) Australia: A$90,858.74